# Photys Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/photys-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.photys.com
- Total disclosed funding: $38M
- Latest round: Series A (Dec 16, 2021)
- Investors on record: 10

## About

Based in Massachusetts, US, and founded in 2021 by Amit Choudhary, Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, Wendy Young, and Eric Fischer, Photys Therapeutics is a pharmaceutical research and development company involved in the development of phosphorylation-inducing chimeric small molecule medicines (PHICS). In September 2022, Photys Therapeutics raised 75 million in Series A led by MPM Capital, with participation from Omega Funds, Longwood fund, 8VC, Arkin Holdings, Mass General Brigham Ventures, MRL Ventures Fund, Merck Ventures, Eli Lilly and Company, and Heritage Medical Systems.

The company's patented platform targets disease proteins and enhances endogenous disease-fighting mechanisms, repairs signaling, and restores protein function to treat a variety of diseases, including cancer, immune, metabolic, and rare diseases. Small molecules are used to unlock finely tuned control of post-translational modifications of proteins.

The company intends to use the September 2022 funding to advance a new class of bifunctional molecules for precision phosphorylation to modulate and repair disease-driving proteins.

## Funding rounds

- Series A, Dec 16, 2021, $38M — MPM BioImpact, M Ventures, Omega Funds, Longwood Fund, Mass General Brigham Ventures, 8VC, Arkin Capital, MRL Ventures Fund, Lilly, Heritage Medical Systems

## Investors

- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Series A
- Omega Funds (https://capitalatlas.ai/funds/omega-funds) — Series A
- Longwood Fund (https://capitalatlas.ai/funds/longwood-fund) — Series A
- Mass General Brigham Ventures (https://capitalatlas.ai/funds/mass-general-brigham-ventures) — Series A
- 8VC (https://capitalatlas.ai/funds/8vc) — Series A
- Arkin Capital (https://capitalatlas.ai/funds/arkin-capital) — Series A
- MRL Ventures Fund (https://capitalatlas.ai/funds/mrl-ventures-fund) — Series A
- Lilly — Series A
- Heritage Medical Systems — Series A